Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China
6
2
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Mechanism and Application of DBS in the Treatment of PD
Role: collaborator
Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection
Role: collaborator
A Clinical Trial on Booster Immunization of Two COVID-19 Vaccines Constructed From Different Technical Routes
Role: collaborator
A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults
Role: lead
A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)
Role: lead
Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults
Role: collaborator
All 6 trials loaded